Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Baricitinib was effective in treating both early and late onset alopecia areata.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Hyaluronic acid filler can safely and effectively improve facial contour in Parry-Romberg Syndrome.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Upadacitinib effectively treats severe alopecia areata and is safe.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Melatonin may treat rosacea and Alzheimer's by reducing inflammation and affecting blood vessel growth.

Neurosteroids may help metyrapone reduce cocaine addiction.

Finasteride may be linked to more psychiatric issues than dutasteride, but a definite cause isn't proven.

Low-dose oral naltrexone may help reduce inflammation in some scarring alopecia patients.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.